openPR Logo
Press release

Perrigo Company plc (NYSE: PRGO) Investor Alert: Deadline in Lawsuit on January 16, 2026

A Deadline is coming up on January 16, 2026 in the lawsuit for certain investors in Perrigo Company plc (NYSE: PRGO).

A Deadline is coming up on January 16, 2026 in the lawsuit for certain investors in Perrigo Company plc (NYSE: PRGO).

A deadline is coming up on January 16, 2026 in the lawsuit filed for certain investors of Perrigo Company plc (NYSE: PRGO) over alleged securities laws violations by Perrigo Company plc.

Investors who purchased shares of Perrigo Company plc (NYSE: PRGO) have certain options and there are strict and short deadlines running. Deadline: January 16, 2026. Perrigo Company plc (NYSE: PRGO) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Perrigo Company plc (NYSE: PRGO) common shares between February 27, 2023 and November 4, 2025, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 27, 2023 and November 4, 2025, the defendants made false and/or misleading statement and/or failed to disclose that the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs, that Perrigo needed to make substantial capital and operational expenditures above Perrigo's outwardly stated cost estimates to remediate the infant formula business, that there were significant manufacturing deficiencies in the facility for Perrigo's infant formula business, and that as a result of the foregoing, Perrigo's financial results, including earnings and cash flow, were overstated.

Those who purchased shares of Perrigo Company plc (NYSE: PRGO) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Perrigo Company plc (NYSE: PRGO) Investor Alert: Deadline in Lawsuit on January 16, 2026 here

News-ID: 4351313 • Views:

More Releases from Shareholders Foundation, Inc.

Skye Bioscience, Inc. (NASDAQ: SKYE) Investor NOTICE: Deadline in Lawsuit on January 16, 2026
Skye Bioscience, Inc. (NASDAQ: SKYE) Investor NOTICE: Deadline in Lawsuit on Jan …
A deadline is coming up on January 16, 2026 in the lawsuit filed for certain investors of Skye Bioscience, Inc. (NASDAQ: SKYE) over alleged securities laws violations by Skye Bioscience, Inc. Investors who purchased shares of Skye Bioscience, Inc. (NASDAQ: SKYE) have certain options and there are strict and short deadlines running. Deadline: January 16, 2026. Skye Bioscience, Inc. (NASDAQ: SKYE) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or
Investigation announced for Long-Term Investors in shares of V.F. Corporation (NYSE: VFC)
Investigation announced for Long-Term Investors in shares of V.F. Corporation (N …
An investigation was announced for long-term investors in shares of V.F. Corporation (NYSE: VFC) concerning potential breaches of fiduciary duties by certain directors of V.F. Corporation. Investors who are current long term investors in V.F. Corporation (NYSE: VFC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: VFC stocks
Lawsuit filed for Investors who lost money with shares of Varonis Systems, Inc. (NASDAQ: VRNS)
Lawsuit filed for Investors who lost money with shares of Varonis Systems, Inc. …
An investor, who purchased shares of Varonis Systems, Inc. (NASDAQ: VRNS), filed a lawsuit over alleged violations of Federal Securities Laws by Varonis Systems, Inc. in connection with certain allegedly false and misleading statements made between February 4, 2025 and October 28, 2025. Investors who purchased shares of Varonis Systems, Inc. (NASDAQ: VRNS) have certain options and for certain investors are short and strict deadlines running. Deadline: March 9, 2026.. NASDAQ:
Investigation announced for Long-Term Investors in shares of Fly-E Group, Inc. (NASDAQ: FLYE)
Investigation announced for Long-Term Investors in shares of Fly-E Group, Inc. ( …
An investigation was announced for investors in shares of Fly-E Group, Inc. (NASDAQ: FLYE) concerning potential breaches of fiduciary duties by certain directors and officers of Fly-E Group, Inc. Investors who are current long term investors in Fly-E Group, Inc. (NASDAQ: FLYE) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors

All 5 Releases


More Releases for Perrigo

Nicotine Patch Market Is Booming So Rapidly | Perrigo, Walgreen, Cigna
The Global Nicotine Patch Market size is estimated at $1.6 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.1% to reach $3.2 Billion by 2034. Download now The latest study released on the Global Nicotine Patch Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Nicotine Patch market study covers significant research data and proofs to be a handy resource
Allergy Treatment Market Booming So Rapidly with Perrigo, Mylan, Novartis
HTF MI recently introduced Global Allergy Treatment Market study with 143+ pages in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status (2024-2032). The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are GlaxoSmithKline, Sanofi, Merck & Co., Pfizer, ALK-Abelló, Stallergenes Greer, Genentech,
Motion Sickness Drugs Market Is Booming Worldwide | Hylands,Perrigo, Viatris
The "Motion Sickness Drugs Market" intelligence report, just published by USD Analytics Market, covers insurers' micro-level study of important market niches, product offers, and sales channels. In order to determine market size, potential, growth trends, and competitive environment, the Motion Sickness Drugs Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major
Baby Formula Market Is Booming Worldwide with Heinz, Bellamy, Perrigo
Baby Formula Market latest research report added by USD Analytics. The Baby Formula Market Study has been segmented by key a region that is accelerating the marketization. The report is a great blend of qualitative and quantitative market data that was gathered and evaluated mostly through primary data and secondary sources. This also provides the scope of different segments and applications that can potentially influence the marketplace in the future.
Global Podophyllin Market 2017-MP Biomedicals ,Perrigo,Himpharm
The report entitled Global Podophyllin Market 2017 presents key insights into the global Podophyllin market along with the latest up-to-date industry details and forthcoming Podophyllin industry trends, which will assist the readers to focus on product specification and end users driving the overall market revenue and profitability. Report Keynotes: The main motive of the report on "Global Podophyllin Market 2017" is to study comprehensive details of the market investors, key industry players
Global Analgesics market 2017 - Crown Pharmaceuticals, Perrigo Company
Global Analgesicsmarket 2017 Research Report offers a complete and in-depth analysis of the growth rate of the Analgesics industry. In the first section, Analgesics Market report presents the overview of Analgesics industry which includes definitions, classifications, applications and Analgesics industry chain structure. Global Analgesics Market further includes Analgesics development history, competitive analysis of Analgesics industry. Top leading Manufacturers Analysis of Analgesics:- 1 Crown Pharmaceuticals 2 Perrigo Company 3 LNK International 4 Medipaams India 5 SRS Pharmaceuticals 6 Umang